EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Determination of Myxovirus Resistance Protein A as a New Biomarker of Viral Infection

Petr Lehnert, Kateřina Štefanová, Julia Werle, Jan Illner, Petra Bukovská, Ondřej Mitrovský, Karel Kotaška, Eva Klapková, Richard Průša, René Kizek

Chemické listy · 15.11.2026 · 120 (11)

DOI: 10.54779/chl20260695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemické listy, online erschienen am 15.11.2026. Verfasst von Petr Lehnert und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of new methods in the field of detection of viral and bacterial pathogens represents a major challenge. A group of acute-phase proteins has been described, including C-reactive protein (CRP), interleukin-6 (IL-6), calprotectin, procalcitonin, serum amyloid A, and MxA (Myxovirus resistance protein A). Their concentration ranges are also highly diverse. Their clinical relevance ranges from distinguishing the nature of the infectious agent (bacteria, virus) to trauma and predictive significance in neoplastic diseases. In routine clinical laboratory medicine, the detection of C-reactive protein levels is standardly used. Recently, however, the MxA molecule has emerged as a new biomarker of viral diseases. This protein has been tested in clinical laboratory practice since 2024, and more than 8,000 determinations have been carried out to date. The bioanalytical determination of the protein is performed using the lateral flow chromatography method, and the detection of the colored product is spectral. Based on available data on the reproducibility of the measuring system, the MxA reference value was calculated for concentration I: 20.3 ± 2.1 ng mL–1, for concentration II 128 ± 13 ng mL–1, and the average bias (%) hovered around –15 %. Experimentally, the MxA level was monitored during vaccination against dengue fever. Initially, the MxA level was around 10 ng mL–1. Within 24 hours, it rose to 59 ng mL–1, after 48 hours it was 22 ng mL–1, and after 196 hours it returned to the baseline of 10 ng mL–1. Furthermore, it was possible to identify the primary diagnosis from the hospital information system, and thus segment the obtained data. Both the median and average MxA concentrations are higher in diseases caused by viruses (above 200 ng mL–1). This was also demonstrated by ROC analysis with an area under the curve (AUC) of 0.58. It was found that the determination of MxA protein in combination with CRP represents a highly valuable examination for the early diagnosis of viral infection and for its differentiation from bacterial infection. High values of both proteins may then indicate a combined infection.

Zitieren

APA

Lehnert, P., Štefanová, K., Werle, J., Illner, J., Bukovská, P., Mitrovský, O., Kotaška, K., Klapková, E., Průša, R., & Kizek, R. (2026). Determination of Myxovirus Resistance Protein A as a New Biomarker of Viral Infection. Chemické listy, 120(11). https://doi.org/10.54779/chl20260695

Vancouver

Lehnert P, Štefanová K, Werle J, Illner J, Bukovská P, Mitrovský O, et al. Determination of Myxovirus Resistance Protein A as a New Biomarker of Viral Infection. Chemické listy. 2026;120(11). doi:10.54779/chl20260695

BibTeX
@article{Lehnert2026,
  author = {Lehnert, Petr and Štefanová, Kateřina and Werle, Julia and Illner, Jan and Bukovská, Petra and Mitrovský, Ondřej and Kotaška, Karel and Klapková, Eva and Průša, Richard and Kizek, René},
  title = {Determination of Myxovirus Resistance Protein A as a New Biomarker of Viral Infection},
  journal = {Chemické listy},
  year = {2026},
  volume = {120},
  number = {11},
  doi = {10.54779/chl20260695}
}
Kostenlos starten →